Skip to content

Social Participation After Childhood Craniopharyngioma

Social Participation After Childhood Craniopharyngioma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03139526
Acronym
CRANIO
Enrollment
20
Registered
2017-05-04
Start date
2014-01-01
Completion date
2014-07-01
Last updated
2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children With a Craniopharyngioma

Keywords

Craniopharyngioma, Children, Social participation, Life-H questionnaire

Brief summary

Craniopharyngioma is a rare, benign central nervous system tumor, which may be a source of multiple complications, from endocrinology to vision, neurology and neurocognitive functions. This morbidity can lead to reduced participation in life activities, as described in the International Classification of Functioning, Disability, and Health (ICF). The primary objective of this study is to measure participation in life activities in a population of children affected by childhood craniopharyngioma, using the assessement of life habits questionnaire (LIFE-H questionnaire), validated as a social participation measurement tool in various pediatric disabilities.

Interventions

OTHERobservational study so no intervention

observational study, so no intervention

Sponsors

BERTHILLIER Julien
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
1 Days to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children with a craniopharyngioma

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
LIFE-H questionnaire (Assessment of Life Habits)At maximum 6 months after inclusionThe LIFE-H questionnaire is sent by mail to parents' patient. For parents who do not return the questionnaire completed, a telephone call is made and the LIFE-H questionnaire is completed by phone.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026